Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Sep 17, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Y-Mabs Therapeutics, Inc.
| -95.00K |
$13.31 | -$1,264,650.00 | -58.40% | 67.68K |
Sep 13 - Sep 16
| |||||||
Y-Mabs Therapeutics, Inc.
| -70.00K |
$12.02 | -$841,050.00 | -30.08% | 162.68K |
Jun 10 - Jun 11
| |||||||
Y-Mabs Therapeutics, Inc.
| -32.35K |
$12.23 | -$395,563.00 | -12.21% | 232.68K |
May 21 - May 23
| |||||||
Y-Mabs Therapeutics, Inc.
| -3.90K |
$16.44 | -$64,116.00 | -2.40% | 158.7K |
Mar 5
| |||||||
Y-Mabs Therapeutics, Inc.
| 22.1K |
—
|
—
| +15.73% | 162.6K |
Jan 18
| |||||||
Y-Mabs Therapeutics, Inc.
| 50K |
$2.00 | $100,000.00 | +55.25% | 140.5K |
Dec 21
| |||||||
Y-Mabs Therapeutics, Inc.
| -150.00K |
$6.67 | -$1,001,000.00 | -36.14% | 265.03K |
Dec 13 - Dec 15
| |||||||
Y-Mabs Therapeutics, Inc.
| -150.00K |
$5.30 | -$795,382.50 | -26.55% | 415.03K |
Nov 20 - Nov 21
| |||||||
Y-Mabs Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Nov 6
| |||||||
Y-Mabs Therapeutics, Inc.
| 40.5K |
—
|
—
| +81.00% | 90.5K |
Jan 17
| |||||||
Y-Mabs Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 18
| |||||||
Y-Mabs Therapeutics, Inc.
| -281.17K |
$7.19 | -$2,021,188.07 | -33.23% | 565.03K |
Feb 7 - Feb 9
| |||||||
Y-Mabs Therapeutics, Inc.
| -136.16K |
$7.75 | -$1,055,557.72 | -13.86% | 846.2K |
Feb 3 - Feb 4
| |||||||
Y-Mabs Therapeutics, Inc.
|
0
|
$6.08 | -$65,160.80 |
—
| 50K |
Feb 1
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -88.06K |
$10.63 | -$936,411.99 | -8.23% | 982.37K |
Jan 24
| |||||||
Y-Mabs Therapeutics, Inc.
| -183.09K |
$11.10 | -$2,033,104.60 | -14.61% | 1.07M |
Jan 20 - Jan 21
| |||||||
Y-Mabs Therapeutics, Inc.
| -69.81K |
$6.61 | -$836,990.39 | -5.08% | 1.3M |
Jan 18 - Jan 19
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
|
0
|
—
|
—
|
—
| 2.71M |
Dec 14
| |||||||
Y-Mabs Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 14
| |||||||
Y-Mabs Therapeutics, Inc.
| -54.00K |
$16.69 | -$901,074.00 | -3.76% | 1.38M |
Dec 6 - Dec 7
| |||||||
Y-Mabs Therapeutics, Inc.
| -47.61K |
$17.11 | -$814,483.25 | -3.21% | 1.44M |
Nov 29 - Nov 30
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
|
0
|
$9.53 | -$752,850.00 |
—
| 50K |
Nov 23
| |||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$19.33 | -$77,302.00 | -0.27% | 1.48M |
Nov 16
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$24.82 | -$99,260.80 | -0.27% | 1.49M |
Oct 29
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$27.20 | -$108,799.20 | -0.27% | 1.49M |
Oct 15
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$28.26 | -$113,054.40 | -0.27% | 1.5M |
Sep 30
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$33.64 | -$134,578.80 | -0.27% | 1.5M |
Sep 15
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
|
0
|
$17.59 | -$1,558,915.00 |
—
| 1.55M |
Sep 2 - Sep 7
| |||||||
Y-Mabs Therapeutics, Inc.
| -29.00K |
$29.35 | -$851,023.29 | -1.83% | 1.55M |
Aug 13 - Aug 17
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$33.73 | -$134,927.20 | -0.25% | 1.58M |
Aug 3
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$32.47 | -$129,875.20 | -0.25% | 1.59M |
Jul 20
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$31.87 | -$127,464.80 | -0.25% | 1.59M |
Jul 7
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$33.86 | -$135,445.60 | -0.25% | 1.6M |
Jun 30
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$35.80 | -$143,217.20 | -0.25% | 1.6M |
Jun 14
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$36.95 | -$147,813.20 | -0.25% | 1.6M |
May 28
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$34.07 | -$136,289.60 | -0.25% | 1.61M |
May 18
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
|
0
|
$14.98 | -$181,730.50 |
—
|
0
|
Apr 26
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$14.31 | -$278,641.20 | -0.25% | 1.61M |
Apr 12
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -6.00K |
$16.13 | -$435,946.20 | -0.37% | 1.62M |
Apr 1
|
Scheduled
| ||||||
Y-Mabs Therapeutics, Inc.
| -4.00K |
$19.39 | -$390,655.80 | -0.25% | 1.62M |
Mar 15
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.